Janus Henderson Group PLC Cardiovascular Systems Inc Transaction History

Janus Henderson Group PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$13.31 - $19.86 $236,332 - $352,634	17,756 New	17,756 $352,000
Q4 2021 Feb 14, 2022	SELL	$18.64 - $36.77 $28.4 Million - $56.1 Million	-1,525,123 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$32.83 - $43.0 $2.62 Million - $3.43 Million	-79,863 Reduced 4.98%	1,525,123 $50.1 Million
Q2 2021 Aug 16, 2021	BUY	$34.41 - $44.03 $8.12 Million - $10.4 Million	235,986 Added 17.24%	1,604,986 $68.5 Million
Q1 2021 May 17, 2021	SELL	$37.29 - $47.19 $11,597 - $14,676	-311 Reduced 0.02%	1,369,000 $52.5 Million
Q4 2020 Feb 16, 2021	BUY	$34.3 - $44.09 $398,222 - $511,884	11,610 Added 0.86%	1,369,311 $59.9 Million
Q3 2020 Nov 16, 2020	SELL	$27.86 - $39.35 $251,380 - $355,055	-9,023 Reduced 0.66%	1,357,701 $53.4 Million
Q2 2020 Aug 14, 2020	BUY	$30.3 - $42.55 $389,597 - $547,107	12,858 Added 0.95%	1,366,724 $43.1 Million
Q1 2020 May 14, 2020	BUY	$30.0 - $54.18 $24.4 Million - $44.1 Million	813,837 Added 150.7%	1,353,866 $47.7 Million
Q4 2019 Feb 18, 2020	BUY	$42.29 - $52.2 $22.6 Million - $27.9 Million	535,085 Added 10822.92%	540,029 $26.2 Million
Q3 2019 Nov 14, 2019	BUY	$42.06 - $51.64 $1,514 - $1,859	36 Added 0.73%	4,944 $234,000
Q2 2019 Jul 31, 2019	SELL	$33.93 - $43.66 $36,847 - $47,414	-1,086 Reduced 18.12%	4,908 $211,000
Q1 2019 Apr 30, 2019	BUY	$26.74 - $41.32 $160,279 - $247,672	5,994 New	5,994 $232,000
Q4 2018 Feb 06, 2019	SELL	$25.26 - $38.43 $130,594 - $198,683	-5,170 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$33.27 - $39.25 $172,005 - $202,922	5,170 New	5,170 $202,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.